In the Pipeline's Derek Lowe says Novartis and Roche are employing some "hardball negotiating" in their fight with the UK government over drug pricing and clinical trial regulations.
To read the full story....
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.